Feasibility of cabazitaxel in octogenarian prostate cancer patients

Paolo Tralongo,Sebastiano Bordonaro,Giuseppe Di Lorenzo,Ugo De Giorgi,Nicolò Borsellino,Gaetano Facchini,Sabrina Rossetti,Giuseppe Fornarini,Vito Longo,Antonino Carmelo Tralongo,Francesca Caspani,Massimiliano Spada,Nicola Calvani,Paolo Carlini

Current Urology（2022）

引用 0|浏览15

暂无评分

摘要

Octogenarian patients can be treated with cabazitaxel with reduced doses or alternative schedules that are associated with less toxicity and fewer treatment interruptions. Comprehensive geriatric assessment could facilitate more appropriate patient selection.

查看译文

关键词

Cabazitaxel, Cancer, Octogenarian, Prostate

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要